Predictors of Surgical Complications and Survival in Pediatric Wilms’ Tumor: A 20-Year Retrospective Study from Two Thai Centers
Current Oncology · 2025
DOI: 10.3390/curroncol32080413 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Current Oncology, 2025. Verfasst von Wison Laochareonsuk und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Surgery, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. Hauptthemen laut MEDLINE: Kidney Neoplasms, Nephrectomy, Postoperative Complications, Wilms Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science, Research, and Innovation Fund.
Abstract (Originalsprache)
(1)
Background
Wilms’ tumor (WT) is the most common pediatric renal malignancy. Although survival outcomes have improved with multimodal therapy, the optimal sequence of surgery and chemotherapy remains debated, particularly in resource-limited settings. This study evaluates the effect of treatment strategy on surgical complications and survival, utilizing two decades of data from Thai tertiary centers. (2)
Methods
A retrospective cohort study was conducted on 83 children who underwent radical nephrectomy for WT between 2002 and 2022 at two university hospitals in Thailand. Patients were grouped by treatment protocol: primary nephrectomy (n = 59) or neoadjuvant chemotherapy (n = 24). Clinical, pathological, operative, and follow-up data were analyzed to identify predictors of surgical complications and survival. (3)
Results
Short-term postoperative complications occurred in 16.9% of cases, more frequently in males and in patients with hypoalbuminemia, anemia, or large tumors. Estimated blood loss greater than 5 mL/kg, serum albumin less than 3.5 g/dL, and hemoglobin lower than 10 g/dL were independent predictors of complications. The five-year overall survival (OS) and progression-free survival (PFS) rates were 82.4% and 68.1%, respectively. Patients with unfavorable histology or short-term complications experienced significantly poorer OS. Neoadjuvant chemotherapy was associated with increased nutritional compromise and a trend toward higher complication rates, although it was not directly linked to inferior OS. (4)
Conclusions
In pediatric WT, the perioperative nutritional and hematologic statuses significantly influence surgical outcomes. While neoadjuvant chemotherapy may assist in tumor downsizing, it might also compromise surgical fitness. Customized preoperative risk assessment and nutritional support can enhance outcomes, particularly in low- and middle-income countries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Surgery, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
- Division of Pediatric Surgery, Department of Surgery, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
- Translational Medicine Research Center, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
ORCID-Profile: Wison Laochareonsuk, Surasak Sangkhathat
Förderung
- National Science, Research, and Innovation Fund
Zitieren
APA
Laochareonsuk, W., Laohapansang, M., Ngerncham, M., & Sangkhathat, S. (2025). Predictors of Surgical Complications and Survival in Pediatric Wilms’ Tumor: A 20-Year Retrospective Study from Two Thai Centers. Current Oncology. https://doi.org/10.3390/curroncol32080413
Vancouver
Laochareonsuk W, Laohapansang M, Ngerncham M, Sangkhathat S. Predictors of Surgical Complications and Survival in Pediatric Wilms’ Tumor: A 20-Year Retrospective Study from Two Thai Centers. Current Oncology. 2025. doi:10.3390/curroncol32080413
BibTeX
@article{Laochareonsuk2025,
author = {Laochareonsuk, Wison and Laohapansang, Mongkol and Ngerncham, Monawat and Sangkhathat, Surasak},
title = {Predictors of Surgical Complications and Survival in Pediatric Wilms’ Tumor: A 20-Year Retrospective Study from Two Thai Centers},
journal = {Current Oncology},
year = {2025},
doi = {10.3390/curroncol32080413}
}
EUVIMED